MobileODT Stock

MobileODT is an AI-based health-tech company that develops medical device technologies for cervical cancer screening.

Sign up today and learn more about MobileODT Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About MobileODT Stock

MobileODT builds small, smart, connected visual diagnostic tools to enable any health provider, anywhere, to conduct examinations on the level of an expert practitioner. Empowering less-trained providers increases the reach of health systems, reducing costs, and improving outcomes. The Enhanced Visual Assessment (EVA) System is our first product, an FDA cleared internet-connected mobile colposcope and is growing rapidly in market share in the US, across Africa, and India. It is used in the world’s harshest environments and receives accolades from clinicians in the world’s leading hospitals (MD Anderson, Mount Sinai, Apollo). EVA has been used for over 40,000 procedures in 29 countries. Our customers include the world’s leading hospital groups West and East, and our fastest-growing market is the US, where we are becoming the standard for visualization (+20% of hospitals in New York State who offer Sexual Assault Forensic Examinations use EVA). We are growing rapidly in new geographies and have in the pipeline additional visual-based applications, including ENT, Oral disease, and Skin.

Funding History

February 2015$2.4M
August 2015$880K
July 2017$6.8M
August 2020$4.0M

Management

CEO

Leon A. Boston

Board Member

Ariel Beery

Investor

Nathaniel Pool

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo